Recruiting minority cancer patients into cancer clinical trials: A pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 1029-1039

  McCaskill Stevens, Worta ^a   Pinto, Harlan ^a   Marcus, Alfred C ^a   Comis, Robert ^a   Morgan, Randall ^a   Plomer, Kathy ^a   Schoentgen, Sarah ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOPHOSPHAMIDE; DOXORUBICIN; FINASTERIDE; ISOTRETINOIN;

ARTICLE; CANCER PATIENT; CLINICAL TRIAL; EDUCATION; HUMAN; INTERPERSONAL COMMUNICATION; MALIGNANT NEOPLASTIC DISEASE; PATIENT REFERRAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUESTIONNAIRE; STAFF;

EID: 0032978081     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.1029     Document Type: Article

References (18)

1. Tejeda HA, Green SB, Trimble EL: Representation of African Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 88:812-816, 1995
2. Hunter CP, Frelick RW, Feldman AR: Selection factors in clinical trials: Results from the Community Clinical Oncology Program physicians' patient log. Cancer Treat Rep 71:559-565, 1987
3. In News: NCI hopes to spur minority enrollment in prevention and screening trials. J Natl Cancer Inst 88:236-237, 1996
4. NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research, Part VIII. 59 Federal Register 14508-14513, 1994
5. Fleetwood M: Clinical trials and cultural diversity. Oncol Issues 8:19-22, 1993
6. Thomas CR, Pinto HA, Roach M: Participation in clinical trials: Is it state-of-the-art treatment for African Americans and other people of color? J Natl Med Assoc 86:177-182, 1994
7. McCabe M, Varricchio C, Padberg R, et al: Efforts to recruit the economically disadvantaged to national clinical trials. Semin Oncol Nurs 10:123-129, 1994
8. Swanson G, Ward A: Recruiting minorities into clinical trials: Toward a participant-friendly system. J Natl Cancer Inst 87:1747-1750, 1995
9. Tuskegee Syphilis Study Ad Hoc Advisory Panel, Final Report of the Tuskegee Syphilis Study Ad Hoc Advisory Panel. Washington, DC, U.S. Department of Health Education and Welfare, Public Health Service, 1973
10. Green BL, Maisiak R, Wang MQ, et al: Participation in health education, health promotion and health research by African Americans: Effects of the Tuskegee syphilis experiment. J Health Educ 28:196-201, 1997
11. Savitt T: The use of blacks for medical experimentation and demonstration in the Old South. J South History 48:331-348, 1982
12. Lederer SE: Subjected to Science, Human Experimentation in America Before the Second World War. Baltimore, MD, The John Hopkins Press, 1995, pp 15, 76, 115
13. Jones HJ: The Tuskegee legacy, AIDS and the black community. Hastings Cent Rep 22:38-40, 1992
14. The recruitment and retention of minority participants in clinical research, in Proceedings of the National Cancer Advisory Board Conference. Washington, DC, U.S. Department of Health and Human Services, National Institutes of Health, 1996
15. Levine D: A partnership with minority populations: A community model of effectiveness research. Ethn Dis 3:2, 1992
16. Moy E: Physician race and care of minority and medically indigent patients. JAMA 273:1515-1520, 1995
17. Komaromy M, Grumbach K, Drake M, et al: The role of black and Hispanic physicians in providing health care for underserved populations. N Engl J Med 334:1305-1310, 1996
18. Kaluzny A, Brawley O, Garson-Angert D: Assuring access to state-of-the-art care for U.S. minority populations: The first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst 85:1945-1950, 1993